Misha M. Riley

898 total citations · 1 hit paper
13 papers, 625 citations indexed

About

Misha M. Riley is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Misha M. Riley has authored 13 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Neurology and 3 papers in Oncology. Recurrent topics in Misha M. Riley's work include Histone Deacetylase Inhibitors Research (4 papers), Protein Degradation and Inhibitors (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Misha M. Riley is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Protein Degradation and Inhibitors (3 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Misha M. Riley collaborates with scholars based in United States, United Kingdom and Italy. Misha M. Riley's co-authors include Jacob M. Hooker, Daniel B. Chonde, Nicole R. Zürcher, Vitaly Napadow, Ciprian Catana, Robert R. Edwards, Marco L. Loggia, Márk Vangel, Ajay D. Wasan and Bruce R. Rosen and has published in prestigious journals such as Journal of Clinical Investigation, Brain and Neuropsychopharmacology.

In The Last Decade

Misha M. Riley

12 papers receiving 615 citations

Hit Papers

Evidence for brain glial ... 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Misha M. Riley United States 8 261 199 146 133 121 13 625
Liang‐Hao Guo Germany 18 363 1.4× 203 1.0× 205 1.4× 210 1.6× 62 0.5× 25 851
Jean-Sébastien Austin Canada 7 449 1.7× 163 0.8× 256 1.8× 95 0.7× 125 1.0× 7 769
Michal Tzadok Israel 15 192 0.7× 146 0.7× 203 1.4× 228 1.7× 163 1.3× 34 746
Guiqiong He China 6 375 1.4× 232 1.2× 87 0.6× 69 0.5× 75 0.6× 7 644
Xuerong Miao China 16 441 1.7× 230 1.2× 261 1.8× 67 0.5× 86 0.7× 28 806
Theodora Kalpachidou Austria 14 223 0.9× 190 1.0× 147 1.0× 35 0.3× 62 0.5× 26 629
Shi-Jie Liu United States 11 218 0.8× 217 1.1× 166 1.1× 68 0.5× 58 0.5× 11 587
Susana Revilla Spain 7 439 1.7× 145 0.7× 159 1.1× 61 0.5× 56 0.5× 8 756
Sydney V. Doss United States 9 247 0.9× 259 1.3× 128 0.9× 76 0.6× 51 0.4× 11 650
Rola Ismail Denmark 13 383 1.5× 154 0.8× 149 1.0× 125 0.9× 52 0.4× 19 718

Countries citing papers authored by Misha M. Riley

Since Specialization
Citations

This map shows the geographic impact of Misha M. Riley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misha M. Riley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misha M. Riley more than expected).

Fields of papers citing papers by Misha M. Riley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misha M. Riley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misha M. Riley. The network helps show where Misha M. Riley may publish in the future.

Co-authorship network of co-authors of Misha M. Riley

This figure shows the co-authorship network connecting the top 25 collaborators of Misha M. Riley. A scholar is included among the top collaborators of Misha M. Riley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misha M. Riley. Misha M. Riley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wu, Chao‐Yi, Chen Liu, Alison J. McManus, et al.. (2025). Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment. Alzheimer s & Dementia Translational Research & Clinical Interventions. 11(1). e70023–e70023. 4 indexed citations
2.
Schwab, Nadine A., Chao‐Yi Wu, Thomas P. DeRamus, et al.. (2023). Feasibility of common, enjoyable game play for assessing daily cognitive functioning in older adults. Frontiers in Neurology. 14. 1258216–1258216. 4 indexed citations
3.
Trombetta, Bianca A., Shona W. Allen, Misha M. Riley, et al.. (2022). Evaluating the biological variability of blood‐based biomarkers for use in clinical trials. Alzheimer s & Dementia. 18(S6).
4.
Riley, Misha M., et al.. (2022). Identification and Prioritization of PET Neuroimaging Targets for Microglial Phenotypes Associated with Microglial Activity in Alzheimer’s Disease. ACS Chemical Neuroscience. 13(24). 3641–3660. 3 indexed citations
5.
Trombetta, Bianca A., Misha M. Riley, Alison J. McManus, et al.. (2022). Using Proteomics Analysis to Identify Cerebrospinal Fluid Biomarkers in Normal Pressure Hydrocephalus. Alzheimer s & Dementia. 18(S5). 1 indexed citations
6.
Jiménez, Carlos, Misha M. Riley, Tiziana Servidei, et al.. (2020). CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models. Cancers. 12(7). 1922–1922. 7 indexed citations
7.
Campbell, Arthur J., Wen‐Ning Zhao, Frederick A. Schroeder, et al.. (2017). HDAC6 Brain Mapping with [18F]Bavarostat Enabled by a Ru-Mediated Deoxyfluorination. ACS Central Science. 3(9). 1006–1014. 61 indexed citations
8.
Bittner, Genevieve C. Van de, Misha M. Riley, Luxiang Cao, et al.. (2017). Nasal neuron PET imaging quantifies neuron generation and degeneration. Journal of Clinical Investigation. 127(2). 681–694. 9 indexed citations
9.
Loggia, Marco L., Daniel B. Chonde, Oluwaseun Akeju, et al.. (2015). Evidence for brain glial activation in chronic pain patients. Brain. 138(3). 604–615. 380 indexed citations breakdown →
10.
Wang, Yajie, Yanling Zhang, Krista M. Hennig, et al.. (2013). Class I HDAC imaging using [3H]CI-994 autoradiography. Epigenetics. 8(7). 756–764. 24 indexed citations
11.
Schroeder, Frederick A., Daniel B. Chonde, Misha M. Riley, et al.. (2013). FDG-PET imaging reveals local brain glucose utilization is altered by class I histone deacetylase inhibitors. Neuroscience Letters. 550. 119–124. 12 indexed citations
12.
Pan, Jen Q., Michael C. Lewis, Elizabeth L. Clore, et al.. (2011). AKT Kinase Activity Is Required for Lithium to Modulate Mood-Related Behaviors in Mice. Neuropsychopharmacology. 36(7). 1397–1411. 88 indexed citations
13.
Wolozin, Benjamin, Shamol Saha, Maria Guillily, Andrew Ferree, & Misha M. Riley. (2008). Investigating Convergent Actions of Genes Linked to Familial Parkinson’s Disease. Neurodegenerative Diseases. 5(3-4). 182–185. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026